LGND 总资产历史(2016–2025)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) 各财年年末总资产(来自 SEC 财报)。
$1.6BFY2025 · FY2016 以来:$601.6M → $1.6B
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $1.6B | +65.7% |
| FY2024 | $941.8M | +19.6% |
| FY2023 | $787.2M | +3.2% |
| FY2022 | $762.7M | -41.2% |
| FY2021 | $1.3B | -4.7% |
| FY2020 | $1.4B | -8.9% |
| FY2019 | $1.5B | +18.6% |
| FY2018 | $1.3B | +87.9% |
| FY2017 | $671.0M | +11.5% |
| FY2016 | $601.6M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议